Purpose: We review the current epidemiological and genetic knowledge regarding
hereditary prostate cancer, and outline its clinical implications. Materials and Methods …

Answer questions and earn CME/CNE Since the dissemination of prostate‐specific antigen
screening, most men with prostate cancer are now diagnosed with localized, low‐risk …

Purpose: β-Catenin is a critical end component of the wnt signaling pathway that regulates
cell growth, apoptosis, and migratory behavior in response to intercellular adhesion …

Discrimination/classification of biological material a ta molecular level is one of the key aims
of chemometrics applied to biospectroscopic data. Two discriminant functions, namely …

Although prostate cancer is a disease of the elderly, its diagnosis is not uncommonly made
in men younger than 55 years. Both ethnic, familial and genetic factors play a role in the …

BACKGROUND Prostate cancer (PCa) affects more than 190,000 men each year with∼
10% of men diagnosed at≤ 55 years, that is, early onset (EO) PCa. Based on historical …

Background Little is known about predictors of prostate cancer severity in young men.
Therefore, we examined whether family history and obesity influence risk of high‐grade …

Purpose: Watchful waiting (WW) is an acceptable strategy for managing prostate cancer
(PC) in older men. Prostate-specific antigen (PSA) testing has resulted in a stage migration …

BACKGROUND Prostate cancer (CaP) is a common disorder with multiple genetic and
environmental factors contributing to the disease. CaP susceptibility loci can be identified …

Prostate cancer is the most common non-skin cancer and the second leading cause of
cancer related mortality for men in the United States. There is strong empirical and …